SANDRA VOSS: Open Payments
NPI 1386664837 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 12 payments from 8 companies in 2025. Trend: 2023 $234 · 2024 $484 · 2025 $817
Food & beverage: $617Education: $200
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $135 |
| Daiichi Sankyo Inc. | 3 | $135 |
| Gilead Sciences, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 2 | $122 |
| ABBVIE INC. | 1 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
Products named: ZEPZELCA, Trodelvy, LIBTAYO, Enhertu, EPKINLY, Nubeqa, FRUZAQLA, CALQUENCE.
Industry payments across DE — which companies pay providers there.
